Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the rank-math domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/maiwald-test.dev5.yoyaba.tech/httpdocs/wp-includes/functions.php on line 6114
IP Due Diligence Und Pharma, |transkript 4-2022 Im November - Spezial: "Patente / M&A / Lizenzierung" – Maiwald

Publication

All publications

IP Due Diligence und Pharma, |transkript 4-2022 im November – Spezial: “Patente / M&A / Lizenzierung”

10 Nov 2022

Market leaders in the life sciences are interested in acquiring start-ups in order to acquire a new technology as soon as their investment risk can be better foreseen. In order to minimise the associated risks, a precise IP due diligence is required on the acquirer’s side. In this article, Dr Marco Stief tries to summarise the most important issues to consider in the article “IP Due Diligence and Pharma” for Transkript.  

To the article in |transkript 4-2022 im November - Spezial: "Patente / M&A / Lizenzierung (german language)